What Five Years of Florida Data Show about Office Surgery Safety

Abstract

Introduction: In 2000, Florida mandated that all physicians report all adverse events occurring in an office setting to a central collecting agency. The purpose here is to analyze the scope and incidence of adverse events and deaths resulting from office surgical procedures in Florida from 2000 to 2005. Methods and Materials: All reported adverse incidents (eg, the death of a patient or ahospital transfer) occurring after an office procedure as reported to the Florida Agency for Health Care Administration from March 1, 2000, through March 1, 2005, were reviewed. Additional information was gained via telephone follow-up and Internet searches. Results: Of 351 reported office adverse events, 110 occurred in association with an office surgical procedure—25 deaths and 85 hospital transfers. Thirteen complications and 5 deaths were clearly associated with use of intravenous sedation anesthesia or general anesthesia. Two deaths and 11 complications were at the hands of anesthesiologists with an MD or DO credential, 2 deaths were attributable to plastic surgeons using intravenous sedation, and 1 death and 2 hospital transfers were attributable to certified registered nurse anesthetists administering anesthesia. No adverse events were associated with use of dilute local (tumescent) anesthesia. Discussion: Dermatologists are currently under scrutiny by legislative and regulatory bodies because they perform liposuction under tumescent local anesthesia in an office setting. But the data from Florida, presented here and elsewhere, clearly show that dermatologists are not the problem. An extraordinarily high percentage of cosmetic surgery deaths and hospital transfers were attributable to board-certified plastic surgeons. A fair analysis of the data indicates that any restrictions on office procedures should start with the specialty demonstrating the most adverse events. State and/or national legislation establishing reporting systems for adverse events should be supported and should require the reporting of delayed deaths. Restrictions on dilute local (tumescent) anesthesia for liposuction would not reduce adverse events and could increase them if patients are forced into liposuction under deeper anesthesia.

Office Surgery Incidents: What Seven Years of Florida Data Show Us

“…These data reveal and solidify some disturbing trends, which have been previously identified in analyses of portions of this data. [1][2][3][4][5][6] Because the data have accumulated over 7 years, the pattern of deaths and injuries has remained consistent with the first year of data. 1 Slightly more than one-half of reports are due to cosmetic procedures and the rest due to medically necessary procedures, most prominently colonoscopy.…”

“…Data from 1 year, 19 months, 3 years, 4 years, and 5 years were published previously by this author and are included for analysis in this article. [1][2][3][4][5][6] A total of 7 years of data, all that are available since the inception of the data collection program, are summarized and analyzed here.…”

Determining the Safety of Office-Based Surgery: What 10 Years of Florida Data and 6 Years of Alabama Data Reveal

“…[1][2][3][4][5][6][7] Since the last report, Florida data collection has continued, but 6 years of office surgery incident reports from the Alabama State Board of Medical Examiners have also been obtained (via special request). The data obtained from 10 and 6 years of adverse event reporting in Florida and Alabama, respectively, are comparable and consistent.…”

“…We have previously reported examinations of the data collected by the state of Florida over 1 year, 19 months, 3 years, 4 years, 5 years, and 7 years. [1][2][3][4][5][6][7] Since the last report, Florida data collection has continued, but 6 years of office surgery incident reports from the Alabama State Board of Medical Examiners have also been obtained (via special request).…”

Advocating for Mandatory Adverse Event Reporting

“…[1][2][3][4][5][6][7] Many patient advocates, including then American Society for Dermatologic Surgery President, Dr. Bill Coleman, and I testified at open hearings before the Florida Board of Medicine (FBM) in 1999. [1][2][3][4][5][6][7] Many patient advocates, including then American Society for Dermatologic Surgery President, Dr. Bill Coleman, and I testified at open hearings before the Florida Board of Medicine (FBM) in 1999.…”